Pfizer, Inc. PFEsaid it plans to invest $600 million in Pfizer Ventures, its venture capital arm. This funding will be invested in small biotechs and other emerging growth companies. About 25% — $150 million — of the newly available fund will be earmarked for companies involved in promising early-stage neuroscience research.
Pfizer Ventures will first invest in companies focussed on neuro-degeneration, neuro-inflammation and neuro-metabolic disorders.Pfizer Boosts Venture Capital Efforts, Neuroscience in Focus
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться